Bioelectronics Corp (BIEL)

[Simpsonly]

Well done art - those numbers are pretty familiar to the Good Guys now, aren't they? The timing of sales plateaus is the tricky speculation and it depends on federal legislation and FDA involvement in the future sales of chemical analgesics.

I would speculate .5 to .75% market share in the first 12-18 months and increases thereafter. I agree with sausage that anything else short-term is dreaming, however, I also think 3 to 5% market share 2 to 5 years out and then who knows is achievable.

When the tsunami of drug-free and side-effect free inexpensive and reliable treatment by the consumer of mild, medium and chronic pain OTC from Walgreens starts rolling in, the numbers and rates of increases will be very positive. Then, factor in greed and the stock will be very, very profitable.